Rubin, K.H., Glintborg, D., Nybo, M., Abrahamsen, B., & Andersen, M. (2017, October). Development and Risk Factors of Type 2 Diabetes in a Nationwide Population of Women With Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism, 102(10), 3848–3857.
Feldman, E.L., Savelieff, M.G., Hayek, S.S., Pennathur, S., Kretzler, M. & Pop-Busui, R. (2020, December). COVID-19 and Diabetes: A Collision and Collusion of Two Diseases. Diabetes, 69 (12) 2549-2565.
Banaszewska, B., Pawelczyk, L., & Spaczynski, R. (2019, December). Current and future aspects of several adjunctive treatment strategies in polycystic ovary syndrome. Reproductive Biology, 19(4), 309-315.
Nas, K., & Tűű, L. (2017, June). A comparative study between myo-inositol and metformin in the treatment of insulin-resistant women. European Review for Medical and Pharmacological Sciences, 21(2 Suppl), 77–82.
Regidor, P. A., & Schindler, A. E. (2016, August). Myoinositol as a Safe and Alternative Approach in the Treatment of Infertile PCOS Women: A German Observational Study. International Journal of Endocrinology, 9537632.
Fruzzetti, F., Perini, D., Russo, M., Bucci, F., & Gadducci, A. (2017, January). Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS). Gynecological Endocrinology: The Official Journal of the International Society of Gynecological Endocrinology, 33(1), 39–42.
Join our Newsletter for charting tips, updates and offers.